-
Announcement on the issuance of "Chemical Generic Drug Reference Preparation Catalog (Forty-fourth Batch)"
Time of Update: 2021-07-29
According to the "Announcement on the Selection and Determination Procedures for the Publication of Reference Preparations for Chemical Generic Drugs" issued by the National Bureau on March 28, 2019 (No.
docx Annex 2: Application Form for Objection to Chemical Generic Drug Reference Preparation.
-
Xuantai Pharmaceutical Science and Technology Innovation Board IPO application accepted, plans to raise 600 million yuan
Time of Update: 2021-07-29
("Xuantai Pharmaceutical" for short) is a high-tech enterprise driven by R&D and innovation, mainly engaged in the research and development, production and sales of high-end generic drugs and CRO services .
-
These 17 varieties encourage imitation!
Time of Update: 2021-07-29
On March 15, the official website of the National Health Commission issued the "Notice on Printing and Distributing the Second Batch of Catalogues of Encouraging Generic Drugs .
The second batch of catalogues of encouraged generic drugs Source: National Health Commission official website
-
Approved 29 new drugs in the first half of the year
Time of Update: 2021-07-29
0 1 Aduhelm (Bojian): The first AD drug to improve disease progression0 2 Breyanzi, Abecma (BMS): CAR-T adds two more members but the competition is fierce0 3 Brexafemme (Synexis): The first new antif
-
Popular science: why some people are born immune to the new coronavirus
Time of Update: 2021-07-29
" The summary is as follows: A new study by MedGenome, a genomic data provider, analyzes why some people who are not infected with the new coronavirus and have not been vaccinated are immune to the disease, or at least avoid serious symptoms .
-
Good news, Sheffield™ 314 lactose monohydrate CDE registration number has been activated
Time of Update: 2021-07-29
Li Jiangning, then director of the General Division of the Drug Registration Department of the State Drug Administration, once compared the original, auxiliary, and package to "parts" and drugs to "complete vehicles".
-
Haichuang Pharmaceuticals Phase 2/3 Clinical Trial of AR Inhibitor Approved in Brazil
Time of Update: 2021-07-29
On July 12, Haichuang Pharmaceutical announced that its "HC-1119 New Coronary Inpatient Treatment Phase 2/3 Clinical Trial" application has been approved by the Brazilian Health Supervision Agency (ANVISA), and relevant clinical trials will be officially launched in Brazil .
-
Health Commission: 24 newly diagnosed cases and 12 local cases are all in Yunnan
Time of Update: 2021-07-29
As of 24:00 on July 10, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 466 confirmed cases (including 3 severe cases), 86,937 cured and discharged cases, and 4,636 deaths.
-
New research: heat-resistant new crown vaccine formula is effective against mutant strains
Time of Update: 2021-07-29
Researchers said that most of the new crown vaccines need to be refrigerated to maintain their effectiveness.
According to reports, the new vaccine formula can remain stable for more than 4 weeks at 37 degrees Celsius, and can be stored for 90 minutes at 100 degrees Celsius .
-
Announcement of the State Drug Administration on Issuing the "Pharmacological Vigilance Quality Management Standards"
Time of Update: 2021-07-29
2. Drug marketing authorization holders and drug registration applicants shall actively prepare for the implementation of the "Pharmacological Vigilance Quality Management Regulations", establish and continuously improve the pharmacovigilance system as required, and standardize the development of pharmacovigilance activities .
-
Baekje, the first listed pharmaceutical company in three places, is coming!
Time of Update: 2021-07-29
Although the innovative drugs Baiyueze and Baizean have been launched from January to September 2020, they have achieved sales revenue of nearly 900 million yuan , But at the same time continue to invest in the expansion of the indications of the listed drugs and other new drug research, so the sales of listed drugs are still at a loss .
-
Nearly 20 original research drugs have encountered patent challenges!
Time of Update: 2021-07-28
Chongqing Yaoyou Pharmaceutical challenged the patent of this pharmaceutical preparation, and the State Intellectual Property Office made a complete invalidation decision on ZL200680007187.
Therefore, after the patent for the original compound expired, domestic generic drugs with approved document numbers flocked to the market .
-
Patients with mild COVID-19 will have symptoms of "long-term COVID-19"
Time of Update: 2021-07-28
International war "epidemic" operation Science and Technology Daily, Beijing, June 24 (Reporter Zhang Mengran) A research analysis of patients with new coronary pneumonia published by the British "Nature Medicine" on the 24th found for the first time that more than half of young and middle-aged (16-30 years old) patients with mild illness who were isolated at home Six months after the initial infection, symptoms of long-lasting dyspnea, loss of taste and smell, fatigue or inattention, and memory loss appeared .
-
Guocai’s "Contract Renewal Season": Is there a sharp increase in drug prices?
Time of Update: 2021-07-28
The company selected for the centralized procurement of cephalexin capsules in the second batch of national organizations is Huabei Pharmaceutical Hebei Huamin Pharmaceutical, the specification is 0.
-
Fosun Pharma/BioNTech establishes a joint venture company in China
Time of Update: 2021-07-28
Regarding the subsequent commercialization of the vaccine, it was agreed that the joint venture company would hire an affiliate of Fosun Pharmaceutical Industry as the CSO to provide marketing and sales services for the mRNA COVID-19 vaccine in China (excluding Hong Kong, Macao and Taiwan), and pay the CSO accordingly.
-
Experts disclose in detail the treatment of people infected with the delta variant
Time of Update: 2021-07-28
Early intervention with Chinese and Western medicine cooperation-experts disclose in detail the treatment of patients infected with delta variant strains Early intervention with Chi
-
The drug review report is out!
Time of Update: 2021-07-28
Priority review approved doubled The report also shows that in 2020, the Center for Drug Evaluation will complete 11,582 registration applications for Chinese medicines, chemical drugs, and biological products (including 4 device combination products, counted by acceptance numbers), an increase of 32.
-
Nuocheng Jianhua's new multi-target RTK inhibitor ICP-033 new drug research application was accepted by the State Food and Drug Administration
Time of Update: 2021-07-28
Biomedical high-tech company Nuocheng Jianhua announced that the company's new multi-target receptor tyrosine kinase (RTK) inhibitor ICP-033 New Drug Research (IND) application has been accepted by the National Medical Products Administration (NMPA) .
-
There is no specific anti-hepatitis E virus, the key lies in prevention
Time of Update: 2021-07-28
Third Affiliated Hospital of Sun Yat-sen, vice liver disease hospital president high Zhiliang, 18, at present there is no anti-hepatitis E virus-specific drugs, the key is prevention .
Elderly people, women of childbearing age, patients with basic liver diseases and other high-risk groups are vaccinated against hepatitis E vaccine .
-
Sharp observation: Why is the powder direct compression process only popular in foreign countries?
Time of Update: 2021-07-28
In fact, compared to wet granulation and tableting, direct compression can better ensure product quality, improve production efficiency, and has a simple process and save raw materials .